Daniel Gras
Daniel Gras is an expert in Cardiology at Confluent Private Hospital (France). As of February 2026, ScienceLeadR ranks Daniel Gras in the top 1% of experts worldwide for Electric Stimulation Therapy. Daniel Gras has authored 199 publications, the most recent in 2025, and is an investigator in 26 clinical trials, 2 of them ongoing. SLR score: 572 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biostatistics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2025
Number : 199
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Impact and safety of remote monitoring of heart failure patients managed with the HeartLogic algorithm: the HeartLogic France Cohort Study. PMID 41624570 — monitoring, ambulatory, safety, hospitalization, heart failure, heart, cohort studies, algorithms, cardiac resynchronization therapy, therapeutics | Eur Heart J Digit Health | 2025 | 0 |
| One-year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication with a Subcutaneous Implantable Cardioverter-defibrillator. PMID 41231774 — arrhythmias, cardiac, communication, tachycardia, therapeutics, defibrillators, implantable, defibrillators | Circ Arrhythm Electrophysiol | 2025 | 0 |
| Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry. PMID 39722592 — diabetes mellitus, registries, comorbidity, mortality, hospitalization, incidence, heart failure, cardiac resynchronization therapy, therapeutics, defibrillators | ESC Heart Fail | 2024 | 0 |
| Temporal trends in population characteristics and type of device among primary prevention implantable cardioverter defibrillator recipients: The DAI-PP programme. PMID 39890483 — heart, cardiovascular diseases, cardiac resynchronization therapy, primary prevention, therapeutics, defibrillators, implantable, defibrillators | Arch Cardiovasc Dis | 2025 | 0 |
| A Modular Communicative Leadless Pacing-Defibrillator System. PMID 38767244 — bradycardia, arrhythmias, cardiac, communication, pulse, defibrillators | N Engl J Med Top journal | 2024 | 73 |
Clinical Studies 26
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years NCT05373940 — mortality, heart failure, heart, secondary prevention, cardiac resynchronization therapy, primary prevention, death, sudden, cardiac, therapeutics, defibrillators, implantable, defibrillators | N/A | Recruiting | 2022 |
| Effectiveness of the EMPOWER Modular Pacing System and EMBLEM Subcutaneous ICD to Communicate Antitachycardia Pacing NCT04798768 — tachycardia, ventricular, research design, arrhythmias, cardiac, communication, tachycardia, posture, therapeutics | N/A | Active not recruiting | 2021 |
LeadR Networks
Main global connection map